Originally published : Thu, Nov 18, 2010 @ 08:08 AM
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the new “pdm” H1N1 signatures from Centers for Disease Control and Prevention (CDC). The new “pdm” panel is optimized to achieve enhanced sensitivity and specificity for H1N1 specimen.
LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.